Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized dexmedetomidine for hemodynamic attenuation during intubation and pneumoperitoneum in morbidly obese patients undergoing laparoscopic bariatric surgery
PACTR202308566462034Not yet recruiting
- Sponsor
- sherif kamal hafez arafa
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in obesity (2 arms), sponsored by sherif kamal hafez arafa. Primary endpoint: Hemodynamic response to intubation and pneumoperitoneum. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
obesity
Beyond the preview
Go deeper on PACTR202308566462034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202308566462034.